-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2022 to 2024.
- Sonnet BioTherapeutics Holdings, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 655K shares, a 405% increase year-over-year.
- Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 655K shares, a 405% increase from 2023.
- Sonnet BioTherapeutics Holdings, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 130K shares, a 34.3% decline from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)